Spectrum of cytokine gene expression in intestinal mucosal lesions of Crohn's disease and ulcerative colitis

Digestion

Volumn 59, Issue 1, 1998, Pages 73-78

  Funakoshi, K ^a   Sugimura, K ^a   Anezaki, K ^a   Bannai, H ^a   Ishizuka, K ^a   Asakura, H ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Crohn's disease; Cytokine mRNA; Reverse transcription polymerase chain reaction; Ulcerative colitis

Indexed keywords

BETA ACTIN; COMPLEMENTARY DNA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CROHN DISEASE; ENTERITIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; COLITIS, ULCERATIVE; CROHN DISEASE; CYTOKINES; FEMALE; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 0031972742     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007470     Document Type: Article

References (37)

1. Pallone F, Fais S, Squarcia O, Biancone L, Pozzilli P, Boirivant M: Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens. Gut 1987;28:745-753.
2. Allison MC, Poulter LW, Dhillon AP, Pounder RE: Immunohistological studies of surface antigen on colonie lymphoid cells in normal and inflamed mucosa. Gastroenterology 1990;99: 421-430.
3. Schreiber S, MacDermott RP, Raedler A, Pinnau R, Bertovich MJ, Nash G: Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease. Gastroenterology 1991;101:1020-1030.
4. Choy MY, Walker-Smith JA, Williams CB, MacDonald TT: Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macarophages in the intestinal lesions in Crohn's disease and ulcerative colitis. Gut 1990;31:1365-1370.
5. Schreiber S, Raedler A, Conn AR, Rombeau JL, MacDermott RP: Increased in vitro release of soluble interleukin-2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease. Gut 1992;33:236-241.
6. Mosmann TR, Coffman RL: TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
7. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A: IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991;146:3444-3451.
8. Breese E, Braegger CP, Corrigan CJ, Walker-Smith JA, MacDonald TT: Interleukin-2-and interferon-γ-secretingT cells in normal and diseased human intestinal mucosa. Immunology 1993;78:127-131.
9. Schreiber S, Heinig T, Thiele H, Raedler A: Immunoregulatory role of interleukin-10 in patients with inflammatory bowel disease. Gastroenterology 1995;108:1434-1444.
10. Niessner M, Volk BA: Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction. Clin Exp Immunol 1995;101:428-435.
11. Kucharzik T, Stoll R, Lügering N, Domschke W: Circulating anti-inflammatory cytokine IL-10 in patients with inflammatory bowel disease. Clin Exp Immunol 1995;100:452-456.
12. Nielsen OH, Køppen T, Rüdiger N, Horn T, Eriksen J, Kirman I: Involvement of interleukin-4 and -10 in inflammatory bowel disease. Dig Dis Sci 1996;41:1786-1793.
13. + lamina propria (LP) lymphokine secretion profile in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996;157:1261-1270.
14. Mahida YR, Wu K, Jewell DP: Enhanced production of interleukin-1β by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut 1989;30:835-838.
15. Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D: Role of interleukin-1 in inflammatory bowel disease-enhanced production during active disease. Gut 1990;31:686-689.
16. Youngman KR, Simon PL, West GA, Cominelli F, Rachmilewitz D, Klein JS, Fiocchi C: Localization of intestinal interleukin-1 activity and protein and gene expression to lamina propria cells. Gastroenterology 1993;104:749-758.
17. Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, Antonioli D, Peppercorn MA, Strom TB: Tumor necrosis factor-α, interleukin-1β, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 1992; 37:818-826.
18. Isaacs KL, Sartor RB, Haskill S: Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992; 103:1587-1595.
19. Raab Y, Gerdin B, Ahlstedt S, Hällgren R: Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis. Gut 1993;34:1203-1206.
20. Mazzucchelli L, Hauser C, Zgraggen K, Wagner H, Hess M, Laissue JA, Mueller C: Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol 1994;144: 997-1007.
21. Braegger CP, Nicholls S, Murch SH, Stephens S, MacDonald TT: Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992;339:89-91.
22. Breese EJ, Michie CA, Nicholls SW, Murch SH, Williams CB, Domizio PWS, MacDonald TT: Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994;106:1455-1466.
23. van Dullemen HM, van Deventer SJH, Hommes DW, Bijl HA, Jansen J, Tytgat GNJ, Woody J: Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995;109: 129-135.
24. Mullis KB, Faloona FA: Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 1987;155:335-350.
25. Wang AM, Dyle MV, Mark DF: Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 1989;86:9717-9721.
26. De Dombal FT, Myren J, Bouchier IAD, Watkinson G, Clamp SE, Softley A: Diagnosis of patients with inflammatory bowel disease - the value of clinical features; in De Dombal FT, Myren J, Bouchier IAD, Watkinson G, Softley A (eds): Inflammatory Bowel Disease, ed 2. Oxford, Oxford University Press, 1993, pp 127-150.
27. Thompson H: The role of rectal biopsy in inflammatory bowel disease; in De Dombal FT, Myren J, Bouchier IAD, Watkinson G, Softley A (eds): Inflammatory Bowel Disease, ed 2. Oxford, Oxford University Press, 1993, pp 177-203.
28. van Hees PAM, van Elteren PM, van Lier JH, van Tangeren JH: An index of inflammatory activity in patients with Crohn's disease. Gut 1980;21:279-286.
29. Truelove SC, Witts LJ: Cortisone in ulcerative colitis: A final report on a therapeutic trial. Br Med J 1955;2:1041-1048.
30. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
31. Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, Modlin RL: Defining protective responses to pathogens: Cytokine profiles in leprosy lesions. Science 1991; 254:277-279.
32. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE: Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-1220.
33. Fiocchi C, Hilfiker ML, Youngman KR, Doerder NC, Finke JH: Interleukin-2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology 1984;86:734-742.
34. Kusugami K, Youngman KR, West GA, Fiocchi C: Intestinal immune reactivity to interleukin-2 differs among Crohn's disease, ulcerative colitis, and controls. Gastroenterology 1989; 97:1-9.
35. Matuura T, West GA, Youngman KR, Klein JS, Fiocchi C: Immune activation genes in inflammatory bowel disease. Gastroenterology 1993;104:448-458.
36. Mullin GE, Lazenby AJ, Harris ML, Bayless TM, James SP: Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 1992;102:1620-1627.
37. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Kahn TA, Mosmann TR: Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990;248:1230-1234.